Edition:
United States

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,590.40GBp
15 Aug 2018
Change (% chg)

30.40 (+1.95%)
Prev Close
1,560.00
Open
1,561.60
Day's High
1,591.00
Day's Low
1,561.60
Volume
9,996,194
Avg. Vol
8,497,510
52-wk High
1,612.80
52-wk Low
1,235.20

Chart for

About

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare... (more)

Overall

Beta: 1.17
Market Cap(Mil.): £76,919.73
Shares Outstanding(Mil.): 4,960.00
Dividend: 19.00
Yield (%): --

Financials

  GSK.L Industry Sector
P/E (TTM): 28.14 28.54 30.58
EPS (TTM): 0.55 -- --
ROI: 10.14 13.15 12.84
ROE: 121.78 15.15 15.02

Long-acting injection a shot in the arm for GSK's HIV business

LONDON A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker's key HIV business.

9:56am EDT

UPDATE 2-Long-acting injection a shot in the arm for GSK's HIV business

* GSK hopes to gain market share from market leader Gilead (Updates with latest GSK and Gilead share price moves)

9:55am EDT

Britain's FTSE steadies as GSK leads health stocks, miners weigh

LONDON, Aug 15 The UK's top share index steadied on Wednesday as a fall across mining stocks capped results-driven gains, with GlaxoSmithKline a standout riser after the result of a clinical trial boosted hopes for its HIV business.

5:08am EDT

Orchard raises $150 million to expand after GSK gene therapy deal

LONDON Anglo-American biotech company Orchard Therapeutics has raised a further $150 million to fund its work in gene therapy, building on earlier fundraisings worth more than $140 million.

Aug 13 2018

Orchard raises $150 mln to expand after GSK gene therapy deal

LONDON, Aug 13 Anglo-American biotech company Orchard Therapeutics has raised a further $150 million to fund its work in gene therapy, building on earlier fundraisings worth more than $140 million.

Aug 13 2018

GlaxoSmithKline appoints HSBC's Iain Mackay as new CFO

LONDON GlaxoSmithKline has named Iain Mackay from global bank HSBC as its new chief financial officer, marking another key appointment by Chief Executive Emma Walmsley as she reshapes the top team at Britain's biggest drugmaker.

Aug 07 2018

UPDATE 1-GlaxoSmithKline appoints HSBC's Iain Mackay as new CFO

* Current CFO Dingemans responsible for 2018 results (Adds details, quote from GSK CEO)

Aug 07 2018

GlaxoSmithKline appoints Iain Mackay as CFO

Aug 7 GlaxoSmithKline Plc said on Tuesday it named Iain Mackay chief financial officer.

Aug 07 2018

GSK to shut Bangladesh drug making factory by end-2018

DHAKA GlaxoSmithKline will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare business, the managing director of its local businesses said on Friday.

Jul 27 2018

GSK to shut Bangladesh drug making factory by end-2018

DHAKA, July 27 GlaxoSmithKline will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare business, the managing director of its local businesses said on Friday.

Jul 27 2018

Earnings vs. Estimates